What does Bellerophon Therapeutics, Inc. do?

Jun 22 2025 06:22 PM IST
share
Share Via
Bellerophon Therapeutics, Inc. is a clinical-stage company focused on developing treatments for cardiopulmonary diseases. It has a market cap of $0.15 million and reported a net profit loss of $2 million as of September 2023.
Overview:
Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company focused on developing products that address medical needs in the treatment of cardiopulmonary diseases, operating within the Pharmaceuticals: Major industry and categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Profit: -2 Million (Quarterly Results - Sep 2023)
Market cap: USD 0.15 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 2,319.92%
Debt Equity: -1.21
Return on Equity: -213.64%
Price to Book: 0.04

Contact Details:
Address: 184 Liberty Corner Rd Ste 302, WARREN NJ: 07059-6796
Tel: 1 908 5744770
Website: http://www.bellerophon.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Bellerophon Therapeutics, Inc.?
Jun 22 2025 05:47 PM IST
share
Share Via